INS and obesity disorder: Likewise, AdipoR agonist enhances insulin sensitivity and exercise endurance [58, 59], extends the shortened lifespan associated with obesity [59], and recovers nonalcoholic steatohepatitis (NASH) and related fibrosis [60].